Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Chemical Science
|
June 14, 2021
Target identification among known drugs by deep learning from heterogeneous networks
Xiangxiang Zeng, Siyi Zhu, Weiqiang Lu, et al.
Cell Reports
|
April 23, 2024
Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's disease
Yunguang Qiu, Yuan Hou, Dhruv Gohel, et al.
Nature Communications
|
February 14, 2026
Combining xQTL and genome-wide association studies from diverse populations improves druggable gene discovery
Noah Lorincz-Comi, Wenqiang Song, Xin Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 6, 2022
Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer's Disease
Grace E Weber, Maria Khrestian, Elizabeth D Tuason, et al.
Scientific Reports
|
December 11, 2019
Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension
Weiling Xu, Suzy A A Comhair, Ruoying Chen, et al.
Science Advances
|
June 11, 2025
SOAR elucidates biological insights and empowers drug discovery through spatial transcriptomics
Yiming Li, Yanyi Ding, Saya Dennis, et al.
Alzheimer'S Research & Therapy
|
January 11, 2022
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease
Jiansong Fang, Pengyue Zhang, Quan Wang, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Interactome mapping in human excitatory neurons reveals novel risk genes and pathways in Alzheimer's disease
Xiaomu Wei, Katie Munechika, Yu Sun, et al.
Chemrxiv : the Preprint Server for Chemistry
|
July 18, 2020
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19
Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Plos Biology
|
November 6, 2020
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Chemical Science
|
June 14, 2021
Target identification among known drugs by deep learning from heterogeneous networks
Xiangxiang Zeng, Siyi Zhu, Weiqiang Lu, et al.
Cell Reports
|
April 23, 2024
Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's disease
Yunguang Qiu, Yuan Hou, Dhruv Gohel, et al.
Nature Communications
|
February 14, 2026
Combining xQTL and genome-wide association studies from diverse populations improves druggable gene discovery
Noah Lorincz-Comi, Wenqiang Song, Xin Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 6, 2022
Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer's Disease
Grace E Weber, Maria Khrestian, Elizabeth D Tuason, et al.
Scientific Reports
|
December 11, 2019
Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension
Weiling Xu, Suzy A A Comhair, Ruoying Chen, et al.
Science Advances
|
June 11, 2025
SOAR elucidates biological insights and empowers drug discovery through spatial transcriptomics
Yiming Li, Yanyi Ding, Saya Dennis, et al.
Alzheimer'S Research & Therapy
|
January 11, 2022
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease
Jiansong Fang, Pengyue Zhang, Quan Wang, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Interactome mapping in human excitatory neurons reveals novel risk genes and pathways in Alzheimer's disease
Xiaomu Wei, Katie Munechika, Yu Sun, et al.
Chemrxiv : the Preprint Server for Chemistry
|
July 18, 2020
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19
Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Plos Biology
|
November 6, 2020
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Page
of 9